Literature DB >> 30104943

Systemic Lupus Erythematosus is a Risk Factor for Complications in Total Joint Arthroplasty.

J Joseph Gholson1, Brandon G Wilkinson1, Timothy S Brown1, Yubo Gao1, S Blake Dowdle1, John J Callaghan1.   

Abstract

Introduction: Systemic Lupus Erythematosus (SLE) has been associated with increased complications following hip and knee arthroplasty. The Purpose of this study was to determine the extent to which SLE is a risk factor in outcomes following total joint arthroplasty (TJA).
Methods: The nationwide inpatient sample was used to identify a cohort of 505,841 patients who had a total hip arthroplasty (THA) or total knee arthroplasty (TKA) between 2009-2011. Of these patients, 2,284 patients (0.45%) had been previously diagnosed with SLE. The impact of SLE on short-term TJA outcomes was determined using multivariate logistic regression. Differences in discharge destination and length of stay were also evaluated.
Results: SLE patients were more likely to have an all-cause medical complication, (OR 1.9, p<0.0001) and more likely to have an all-cause surgical complication (OR 1.3, p<0.0001). SLE patients were four times more likely to become septic in the post-operative period (OR 3.8, p<0.0487). SLE patients were more likely to have a genitourinary complication (OR 1.7, p<0.0001) and bleeding complications requiring transfusion (OR 2.1, p<0.0001). Patients with SLE also had an increased length of stay (0.38 days, p<0.0001) and increased probability of discharging to a facility (OR 2.1, p<0.0001). Discussion: Patients with SLE had an increased rate of both medical and surgical all-cause complications. Patients were specifically found to be at higher risk for sepsis, genitourinary complications, and blood transfusions. Future risk adjustment models should include SLE as a contributor to medical and surgical complications in the postoperative period.

Entities:  

Keywords:  Nationwide Inpatient Sample (NIS); SLE; Total hip arthroplasty; sepsis; short-term complications; systemic lupus erythematosus; total knee arthroplasty

Mesh:

Year:  2018        PMID: 30104943      PMCID: PMC6047393     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  48 in total

1.  Total Hip Arthroplasty Outcomes: An 18-Year Experience in a Single Center: Is Systemic Lupus Erythematosus a Potential Risk Factor for Adverse Outcomes?

Authors:  Javier Merayo-Chalico; Marco Gónzalez-Contreras; Rigoberto Ortíz-Hernández; Jorge Alcocer-Varela; David Marcial; Diana Gómez-Martín
Journal:  J Arthroplasty       Date:  2017-06-19       Impact factor: 4.757

2.  Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program.

Authors:  Emily C Somers; Wendy Marder; Patricia Cagnoli; Emily E Lewis; Peter DeGuire; Caroline Gordon; Charles G Helmick; Lu Wang; Jeffrey J Wing; J Patricia Dhar; James Leisen; Diane Shaltis; W Joseph McCune
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

3.  The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry.

Authors:  S Sam Lim; A Rana Bayakly; Charles G Helmick; Caroline Gordon; Kirk A Easley; Cristina Drenkard
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

4.  Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus: a midterm follow-up study of 28 hips in 24 patients.

Authors:  Yan Kang; Zi-ji Zhang; Xiao-yi Zhao; Zhi-qi Zhang; Pu-yi Sheng; Wei-ming Liao
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-02-05

5.  Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus.

Authors:  Su Jin Jeong; Heekyung Choi; Han Sung Lee; Sang Hoon Han; Bum Sik Chin; Ji-Hyeon Baek; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Scand J Infect Dis       Date:  2009

6.  Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome.

Authors:  C J Edwards; T Y Lian; H Badsha; C L Teh; N Arden; H H Chng
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 7.  Current Perspectives on Arthroplasty in Systemic Lupus Erythematosus: Rates, Outcomes, and Adverse Events.

Authors:  Shanthini Kasturi; Susan Goodman
Journal:  Curr Rheumatol Rep       Date:  2016-09       Impact factor: 4.592

8.  Perioperative Complications in Patients With Inflammatory Arthropathy Undergoing Total Hip Arthroplasty.

Authors:  Erik A Schnaser; James A Browne; Douglas E Padgett; Mark P Figgie; Michele R D'Apuzzo
Journal:  J Arthroplasty       Date:  2016-03-21       Impact factor: 4.757

9.  Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies.

Authors:  F A Houssiau; A N'Zeusseu Toukap; G Depresseux; B E Maldague; J Malghem; J P Devogelaer; B C Vande Berg
Journal:  Br J Rheumatol       Date:  1998-04

10.  All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre.

Authors:  June Lee; Nimrit Dhillon; Janet Pope
Journal:  Rheumatology (Oxford)       Date:  2013-01-09       Impact factor: 7.580

View more
  2 in total

1.  Chronic steroid use and readmission following total shoulder arthroplasty.

Authors:  Kenny Ling; Matthew Kim; Alireza Nazemi; Emma Smolev; David E Komatsu; Edward D Wang
Journal:  JSES Int       Date:  2022-07-14

2.  The impact of systemic lupus erythematosus on the risk of infection after total hip arthroplasty: a nationwide population-based matched cohort study.

Authors:  Chien-Hao Chen; Tien-Hsing Chen; Yu-Sheng Lin; Dave W Chen; Chi-Chin Sun; Liang-Tseng Kuo; Shih-Chieh Shao
Journal:  Arthritis Res Ther       Date:  2020-09-14       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.